CSAM Health Group AS
CSAM Health Group AS Fundamental Analysis
CSAM Health Group AS (CSAMF) shows moderate financial fundamentals with a PE ratio of -40.39, profit margin of -9.55%, and ROE of -1.12%. The company generates $0.3B in annual revenue with moderate year-over-year growth of 3.53%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -106.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze CSAMF's fundamental strength across five key dimensions:
Efficiency Score
WeakCSAMF struggles to generate sufficient returns from assets.
Valuation Score
ExcellentCSAMF trades at attractive valuation levels.
Growth Score
WeakCSAMF faces weak or negative growth trends.
Financial Health Score
WeakCSAMF carries high financial risk with limited liquidity.
Profitability Score
WeakCSAMF struggles to sustain strong margins.
Key Financial Metrics
Is CSAMF Expensive or Cheap?
P/E Ratio
CSAMF trades at -40.39 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, CSAMF's PEG of -0.13 indicates potential undervaluation.
Price to Book
The market values CSAM Health Group AS at 29.07 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 14.25 times EBITDA. This signals the market has high growth expectations.
How Well Does CSAMF Make Money?
Net Profit Margin
For every $100 in sales, CSAM Health Group AS keeps $-9.55 as profit after all expenses.
Operating Margin
Core operations generate 2.78 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-1.12 in profit for every $100 of shareholder equity.
ROA
CSAM Health Group AS generates $-3.05 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
CSAM Health Group AS generates strong operating cash flow of $87.48M, reflecting robust business health.
Free Cash Flow
CSAM Health Group AS generates strong free cash flow of $65.27M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $3.18 in free cash annually.
FCF Yield
CSAMF converts 6.65% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-40.39
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.13
vs 25 benchmark
P/B Ratio
Price to book value ratio
29.07
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.92
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
14.85
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.73
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-1.12
vs 25 benchmark
ROA
Return on assets percentage
-0.03
vs 25 benchmark
ROCE
Return on capital employed
0.01
vs 25 benchmark
How CSAMF Stacks Against Its Sector Peers
| Metric | CSAMF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -40.39 | 28.25 | Better (Cheaper) |
| ROE | -111.66% | 780.00% | Weak |
| Net Margin | -9.55% | -20122.00% (disorted) | Weak |
| Debt/Equity | 14.85 | 0.30 | Weak (High Leverage) |
| Current Ratio | 0.73 | 4.66 | Weak Liquidity |
| ROA | -3.05% | -14687.00% (disorted) | Weak |
CSAMF outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews CSAM Health Group AS's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
1764.89%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
-1387.87%
Industry Style: Defensive, Growth, Innovation
DecliningFCF CAGR
2201.83%
Industry Style: Defensive, Growth, Innovation
High Growth